Email updates

Keep up to date with the latest news and content from BMC Proceedings and BioMed Central.

This article is part of the supplement: Beyond the Genome 2012

Open Access Oral presentation

Epigenetic reprogramming in the epithelial-to-mesenchymal transition

Stephen Hoang*, Marcin Cieślik, Sanjay Chodaparambil, Natalya Baranova, Manish Kumar, David Allison, Jake Wamsley, Lisa Gray, Marty Mayo and Stefan Bekiranov

  • * Corresponding author: Stephen Hoang

  • † Equal contributors

Author affiliations

Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, VA, USA

For all author emails, please log on.

Citation and License

BMC Proceedings 2012, 6(Suppl 6):O28  doi:10.1186/1753-6561-6-S6-O28


The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1753-6561/6/S6/O28


Published:1 October 2012

© 2012 Hoang et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Oral presentation

The epithelial-to-mesenchymal transition (EMT) is a cellular dedifferentiation process that is critical to development, wound healing and metastasis. Like other cell state transitions, such as differentiation, EMT is accompanied by genome-wide epigenetic reprogramming. However, the relationship between reprogramming and functional changes in the cell is poorly understood. In an A549 non-small cell lung cancer EMT model system we observed changes in chromatin state between epithelial and mesenchymal states. Multivariate analyses were applied to paired (epithelial and mesenchymal) ChIP-seq data for 18 histone modifications/variants and expression microarray data. We observed epigenetic co-regulation of genes associated with EMT, as well as their proximal enhancers. We also observed epigenetic activation or repression of functionally distinct sets of enhancers. These genes and enhancers are regulated and bound by a small set of transcription factors, specifically AP-1, NF-κB and c-Myc. These transcription factors themselves also a show an epigenetic profile similar to the EMT-related genes. Together, these observations suggest a chromatin-mediated transcriptional feedback mechanism that establishes and maintains the phenotypic switch.